COMPOSITION CONTAINING AN SCHISANDRAE FRUCTUS EXTRACT FOR PREVENTING AND TREATING METABOLIC BONE DISEASES, OXIDATIVE STRESS-INDUCED DISEASES AND INFLAMMATORY DISEASES

摘要

A pharmaceutical composition comprising an extract of Schizandrae Fructus is provided to increase bone marrow mineralization and bone matrix protein synthesis and show anti-oxidative and anti-inflammatory effects, thereby being used for treating and preventing metabolic bone diseases, oxidative stress-induced diseases and inflammatory diseases. A composition for preventing and treating metabolic bone diseases, oxidative stress-induced diseases and inflammatory diseases comprises an extract of Schizandrae Fructus obtained by using a solvent selected from the group consisting of C1-4 alcohol, a mixture solvent of C1-4 alcohol and water, lower acetate, acetone, chloroform, dichloromethane, carbon tetrachloride, methylene chloride, ether, petroleum ether and hexane. The composition further comprises a pharmaceutically acceptable inert carrier such as a diluent, a flavoring agent, a solubilizer, a lubricant, a suspending agent, a binder, and a disintegrator.